- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced, Refractory Cancer
Total 56925 results
-
Bristol-Myers SquibbCompletedAdvanced Solid CancersUnited States, Canada
-
M.D. Anderson Cancer CenterPfizerCompleted
-
M.D. Anderson Cancer CenterTerminated
-
M.D. Anderson Cancer CenterNational Center for Research Resources (NCRR)UnknownAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterNational Center for Research Resources (NCRR)UnknownAdvanced CancersUnited States
-
Yale UniversityCelgene CorporationTerminatedAdvanced Solid CancersUnited States
-
New Epsilon Innovation LimitedActive, not recruitingAdvanced Solid Tumor | Relapsed AML | Refractory AMLHong Kong
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | BRAF Gene MutationUnited States
-
Roswell Park Cancer InstituteNot yet recruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal Adenocarcinoma and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAdvanced CancersUnited States
-
Polaris GroupTerminated
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Yale UniversityAgennixCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University Health Network, TorontoActive, not recruitingAdvanced Cancer | Immunotherapy | Radiation Therapy | PalliativeCanada
-
Massachusetts General HospitalCompletedAdvanced Cancer | Home Care, Hospital-BasedUnited States
-
Novartis PharmaceuticalsTerminatedCancer | Solid Tumor | Advanced Solid TumorJapan
-
Ascenta TherapeuticsTerminatedLocally Advanced Esophageal or GE Junction CancerUnited States
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Head, Neck and Chest CancerChina
-
GeneScience Pharmaceuticals Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsUnknownAdvanced Gastric or Gastroesophageal Junction CancerChina
-
TaiRx, Inc.CompletedCarcinoma | Advanced CancerTaiwan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Southern Europe New Drug OrganizationClinical Trial Unit Ente Ospedaliero CantonaleCompletedAdvanced Head and Neck Squamous Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedCancer | Advanced Solid Tumors | TumorsUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingAdvanced Breast Cancer | Advanced Solid Tumor | Advanced Gastric CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Fondazione IRCCS Policlinico San Matteo di PaviaUniversity of PaviaRecruiting
-
National Taiwan University HospitalNot yet recruiting
-
Immatics US, Inc.CompletedCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerUnited States, Germany
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Liver CancerUnited States
-
Immatics Biotechnologies GmbHRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
Sameek RoychowdhuryActive, not recruitingCholangiocarcinoma | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
M.D. Anderson Cancer CenterCompletedSolid Tumors | Advanced CancersUnited States
-
University College, LondonNot yet recruitingAdvanced Cancer
-
Wuxi People's HospitalRecruitingSolid Tumor | Advanced CancerChina
-
Daiichi Sankyo Co., Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerJapan, United States, Canada
-
Merck Sharp & Dohme LLCCompletedNeoplasms | Cancer | Metastatic Solid Tumors | Locally Advanced Tumors
-
M.D. Anderson Cancer CenterPfizerTerminated
-
Immatics Biotechnologies GmbHBristol-Myers SquibbRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fonds Gaston Ithier; Association Jules BordetRecruiting